Black Diamond Therapeutics (BDTX) Change in Acquisitions & Divestments (2020 - 2025)

Black Diamond Therapeutics' Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $33.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 7.35% year-over-year to $33.0 million; the TTM value through Dec 2025 reached $119.1 million, down 14.78%, while the annual FY2025 figure was $119.1 million, 14.78% down from the prior year.
  • Change in Acquisitions & Divestments reached $33.0 million in Q4 2025 per BDTX's latest filing, up from $23.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $45.0 million in Q1 2021 to a low of $23.5 million in Q3 2025.
  • Average Change in Acquisitions & Divestments over 3 years is $33.8 million, with a median of $32.0 million recorded in 2025.
  • The largest YoY upside for Change in Acquisitions & Divestments was 7.35% in 2025 against a maximum downside of 24.49% in 2025.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at $45.0 million in 2021, then plummeted by 31.73% to $30.8 million in 2024, then grew by 7.35% to $33.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Change in Acquisitions & Divestments are $33.0 million (Q4 2025), $23.5 million (Q3 2025), and $30.6 million (Q2 2025).